Causes of death among persons with aids in the era of highly active antiretroviral therapy: New York City

Annals of Internal Medicine

Volumn 145, Issue 6, 2006, Pages 397-406

  Sackoff, Judith E ^a   Hanna, David B ^a   Pfeiffer, Melissa R ^a   Torian, Lucia V ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; UNITED STATES; ADDICTION; DEATH CERTIFICATE; NEOPLASM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DEATH CERTIFICATES; FEMALE; HOMOSEXUALITY, MALE; HUMANS; MALE; NEOPLASMS; NEW YORK CITY; SUBSTANCE-RELATED DISORDERS;

EID: 33749175714     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-145-6-200609190-00003     Document Type: Article

References (53)

1. Sepkowitz KA. AIDS - the first 20 years. N Engl J Med. 2001;344:1764-72.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60.
3. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ. 1999;48:1-22.
4. Centers for Disease Control and Prevention. Trends in Annual Age-Adjusted Rate of Death due to HIV Disease, USA, 1987-2002. Atlanta: Centers for Disease Control and Prevention; last updated 27 June 2005. Accessed at www.cdc.gov/hiv/graphics/images/l285/l285-4.htm on 29 June 2005.
5. Selik R, Singh T, Hsu L. The proportion of deaths due to HIV infection among persons with AIDS in New York City and San Francisco during 1987-1999 [Abstract]. Presented at the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, 8-11 February 2004. Abstract no. 871.
6. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-71.
7. Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-30.
8. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186:1023-7.
9. Vandentorren S, Mercié P, Marimoutou C, Neau D, Malvy D, Farbos S, et al. Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997. Eur J Epidemiol. 2001;17:7-10.
10. Prins M, Hernández Aguado IH, Brettle RP, Robertson JR, Broers B, Carré N, et al. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users. AIDS. 1997;11:1747-56.
11. Smith DK, Gardner LI, Phelps R, Hamburger ME, Carpenter C, Klein RS, et al. Mortality rates and causes of death in a cohort of HIV-infected and un-infected women, 1993-1999. J Urban Health. 2003;80:676-88.
12. Prins M, Sabin CA, Lee CA, Devereux H, Coutinho RA. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS. 2000;14:1829-37.
13. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609-29.
14. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6:99-106.
15. Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 2002;3:195-9.
16. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492-7.
17. Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004;39:1380-4.
18. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active anti-retroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
19. Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS. 2006;20:741-9.
20. New York City Department of Health and Mental Hygiene. HIV Epidemiology Program 1st Quarter Report. New York: New York City Department of Health and Mental Hygiene; January 2005.
21. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
22. Greenberg AE, Hindin R, Nicholas AG, Bryan EL, Thomas PA. The completeness of AIDS case reporting in New York City. JAMA. 1993;269:2995-3001.
23. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization; 1993.
24. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156:471-82.
25. Lee LM, McKenna MT, Janssen RS. Classification of transmission risk in the national HIV/AIDS surveillance system. Public Health Rep. 2003;118:400-7.
26. Selik RM, Anderson RN, McKenna MT, Rosenberg HM. Increase in deaths caused by HIV infection due to changes in rules for selecting underlying cause of death. J Acquir Immune Defic Syndr. 2003;32:62-9.
27. New York City Department of Health and Mental Hygiene Bureau of Vital Statistics. The Summary of Vital Statistics 2003: The City of New York. New York: New York City Department of Health and Mental Hygiene; December 2004.
28. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr. 2002;31:536-41.
29. Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr. 2002;29:378-87.
30. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep. 2003;52:1-115.
31. Alcohol-attributable deaths and years of potential life lost - United States, 2001. MMWR Morb Mortal Wkly Rep. 2004;53:866-70.
32. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18:2285-93.
33. U.S. Census Bureau. United States Census 2000. Accessed at www.census.gov/main/www/cen2000.html on 31 August 2004.
34. National Center for Health Statistics, Centers for Disease Control and Prevention. Vital Statistics of the United States: Mortality, 1995: Technical Appendix. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; April 1999.
35. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Hoboken, NJ: J Wiley; 1987.
36. Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analyst's perspective. Multivariate Behavioral Research. 1998;33:545-71.
37. Royston P. Multiple imputation of missing values: update. Stata Journal. 2005;5:188-201.
38. Royston P. Multiple imputation of missing values: update of ice. Stata Journal. 2005;5:527-36.
39. Molenberghs G, Williams PL, Lipsitz SR. Prediction of survival and opportunistic infections in HIV-infected patients: a comparison of imputation methods of incomplete CD4 counts. Stat Med. 2002;21:1387-408.
40. Casau NC. Perspective on HIV infection and aging: emerging research on the horizon. Clin Infect Dis. 2005;41:855-63.
41. Arday DR, Erdin BR, Giovino GA, Nelson DE. Smoking, HIV infection, and gay men in the United States. Tob Control. 1993;2:156-8.
42. Niaura R, Shadel WG, Morrow K, Flanigan T, Abrams DB. Smoking among HIV-positive persons [Abstract]. Ann Behav Med. 1999;21(Suppl):S116.
43. Cigarette smoking among adults - United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51:642-5.
44. Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6:71-7.
45. Lethbridge-Cejku M, Schiller JS, Bernadel L. Summary health statistics for U.S. adults: National Health Interview Survey, 2002. Vital Health Stat 10. 2004:1-151.
46. Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16 Suppl 1:S22-42.
47. Weber R, Friis-Møller N, Sabin CA, Reiss P, D'Arminio Monforte A, Dabis F, et al. HIV and non-HIV-related deaths and their relationship to immunodeficiency: the D:A:D study [Abstract]. Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 22-25 February 2005. Abstract no. 595.
48. New York City Department of Health and Mental Hygiene. Take Care New York: A Policy for a Healthier New York City. New York: New York City Department of Health and Mental Hygiene; March 2004. Accessed at www.nyc.gov/html/doh/downloads/pdf/tcny/tcny-policy.pdf on 1 November 2005.
49. New York State Department of Health AIDS Institute. Smoking Cessation in HIV-Infected Patients. Albany, NY: New York State Department of Health AIDS Institute; updated June 2005. Accessed at www.hivguidelines.org/ public_html/sub-smoking/sub-smoking.htm on 2 November 2005.
50. Frieden TR, Mostashari F, Kerker BD, Miller N, Hajat A, Frankel M. Adult tobacco use levels after intensive tobacco control measures: New York City, 2002-2003. Am J Public Health. 2005;95:1016-23.
51. Miller N, Frieden TR, Liu SY, Matte TD, Mostashari F, Deitcher DR, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005;365:1849-54.
52. New York State Department of Health AIDS Institute. Screening and Ongoing Assessment for Substance Use. Albany, NY: New York State Department of Health AIDS Institute; March 2005. Accessed at www.hivguidelines.org/ public_html/sub-screen/sub-screening.htm on 2 November 2005.
53. Bernicker EH, Atmar RL, Schaffner DL, Greenberg SB. Unanticipated diagnoses found at autopsy in an urban public teaching hospital. Am J Med Sci. 1996;311:215-20.